A detailed history of Gs Investments, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Gs Investments, Inc. holds 13 shares of MRNA stock, worth $1,536. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13
Previous 13 -0.0%
Holding current value
$1,536
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024

SELL
$69.51 - $104.43 $2,432 - $3,655
-35 Reduced 72.92%
13 $1,000
Q4 2021

Feb 09, 2022

BUY
$225.82 - $368.51 $10,839 - $17,688
48 New
48 $12,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $46.2B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Gs Investments, Inc. Portfolio

Follow Gs Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gs Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gs Investments, Inc. with notifications on news.